Abstract
Hematologic primary prophylaxis is the gold standard of treatment in persons with hemophilia (PWH). The goal is to reduce or prevent joint bleeds and subsequent joint degeneration (hemophilic arthropathy). In acute hemarthroses, early treatment with factor VIII or factor IX (FVIII or FIX) replacement and rest of the joint (4–5 days) is paramount. In patients with inhibitors (antibodies against FVIII or FIX) we can use bypassing agents such as activated prothrombin complex concentrates (aPCCs) and recombinant factor VIIa (rFVIIa). The goal is to get the rapid resolution of the joint bleed that must be confirmed by means of ultrasonography (US). This way the risk of long-term complications will be minimized. Ice therapy could help, although its current role in hemophilia remains controversial. Pain killers (paracetamol) may also be needed. Arthrocentesis (joint aspiration) should be performed in very tense and painful joints. The procedure should always be performed under factor coverage and in aseptic conditions.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Simpson ML, Valentino LA. Management of joint bleeding in hemophilia. Expert Rev Hematol. 2012;5:459–68.
Rodriguez-Merchan EC, De la Corte-Garcia H. Musculoskeletal manifestations of hemophilia. In: Rodríguez-Merchan EC, editor. Joint surgery in the adult patient with hemophilia. Cham: Springer; 2015. p. 1–12.
Rodriguez-Merchan EC. Articular bleeding in hemophilia. Cardiovasc Hematol Disord Drug Targets. 2016;16:21–4.
Rodriguez-Merchan EC. Pathogenesis, early diagnosis, and prophylaxis for chronic hemophilic synovitis. Clin Orthop Relat Res. 1997;343:6–11.
Rodriguez-Merchan EC. Management of musculo-skeletal complications of hemophilia. Semin Thromb Hemost. 2003;29:87–96.
Rodriguez-Merchan EC. Effects of hemophilia on articulations of children and adults. Clin Orthop Relat Res. 1996;328:7–13.
Rodriguez-Merchan EC, Magallon M, Galindo E, Lopez-Cabarcos C. Hemophilic synovitis of the knee and elbow. Clin Orthop Relat Res. 1997;343:47–53.
Dunn AL. Pathophysiology, diagnosis and prevention of arthropathy in patients with haemophilia. Haemophilia. 2011;17:571–8.
Valentino LA, Hakobyan N, Enockson C, Simpson ML, Kakodkar NC, Cong L, et al. Exploring the biological basis of haemophilic joint disease: experimental studies. Haemophilia. 2012;18:310–8.
Roosendaal G, Lafeber FP. Pathogenesis of haemophilic arthropathy. Haemophilia. 2006;12(3):117–21.
Rodriguez-Merchan EC, Jimenez-Yuste V, Aznar JA, Hedner U, Knobe K, Lee CA, et al. Joint protection in haemophilia. Haemophilia. 2011;17(2):1–23.
Manco-Johnson MJ, Abshire TC, Shapiro AD, Riske B, Hacker MR, Kilcoyne R, et al. Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia. N Engl J Med. 2007;357:535–44.
Srivastava A, Brewer AK, Mauser-Bunschoten EP, Key NS, Kitchen S, Llinas A, et al. Treatment Guidelines Working Group on Behalf of The World Federation of Hemophilia. Guidelines for the management of hemophilia. Haemophilia. 2013;19:1–47.
Carcao M, Lambert T. Prophylaxis in haemophilia with inhibitors: update from international experience. Haemophilia. 2010;16(2):16–23.
Hermans C, De Moerloose P, Fischer K, Holstein K, Klamroth R, Lambert T, et al. Management of acute haemarthrosis in haemophilia A without inhibitors: literature review, European survey and recommendations. Haemophilia. 2011;17:383–92.
Valentino LA, Hakobyan N, Enockson C. Blood-induced joint disease: the confluence of dysregulated oncogenes, inflammatory signals, and angiogenic cues. Semin Hematol. 2008;45(2):S50–7.
Valentino LA, Hakobyan N, Rodriguez N, Hoots WK. Pathogenesis of haemophilic synovitis: experimental studies on blood-induced joint damage. Haemophilia. 2007;13(3):10–3.
Querol F, Rodriguez-Merchan EC. The role of ultrasonography in the diagnosis of the musculo-skeletal problems of haemophilia. Haemophilia. 2012;18:e215–26.
De la Corte-Rodriguez H, Rodriguez-Merchan EC, Alvarez-Roman MT, Martin-Salces M, Romero-Garrido JA, Jimenez-Yuste V. Accelerating recovery from acute hemarthrosis in patients with hemophilia: the role of joint aspiration. Blood Coagul Fibrinolysis. 2019;30:111–9.
Nieuwenhuizen L, Roosendaal G, Coeleveld K, Lubberts E, Biesma DH, Lafeber FP, et al. Haemarthrosis stimulates the synovial fibrinolytic system in haemophilic mice. Thromb Haemost. 2013;110:173–83.
Nieuwenhuizen L, Schutgens RE, Coeleveld K, Mastbergen SC, Roosendaal G, Biesma DH, et al. Hemarthrosis in hemophilic mice results in alterations in M1-M2 monocyte/macrophage polarization. Thromb Res. 2014;133:390–5.
Ravanbod R, Torkaman G, Esteki A. Biotribological and biomechanical changes after experimental haemarthrosis in the rabbit knee. Haemophilia. 2011;17:124–33.
Gringeri A, Ewenstein B, Reininger A. The burden of bleeding in haemophilia: is one bleed too many? Haemophilia. 2014;20:459–63.
Berntorp E. Importance of rapid bleeding control in haemophilia complicated by inhibitors. Haemophilia. 2011;17:11–6.
Smejkal P, Brabec P, Matyskova M, Bulikova A, Slechtova M, Kissova J, et al. FEIBA in treatment of acute bleeding episodes in patients with haemophilia A and factor VIII inhibitors: a retrospective survey in regional haemophilia centre. Haemophilia. 2009;15:743–51.
Young G, Auerswald G, Jimenez-Yuste V, Konkle BA, Lambert T, Morfini M, et al. When should prophylaxis therapy in inhibitor patients be considered? Haemophilia. 2011;17:849–57.
de Paula EV, Kavakli K, Mahlangu J, Ayob Y, Lentz SR, Morfini M, et al. Recombinant factor VIIa analog (vatreptacog alfa [activated]) for treatment of joint bleeds in hemophilia patients with inhibitors: a randomized controlled trial. J Thromb Haemost. 2012;10:81–9.
Forsyth AL, Zourikian N, Valentino LA, Rivard GE. The effect of cooling on coagulation and haemostasis: should “Ice” be part of treatment of acute haemarthrosis in haemophilia? Haemophilia. 2012;18:843–50.
Rodriguez-Merchan EC. Treatment of musculo-skeletal pain in haemophilia. Blood Rev. 2018;32:116–21.
Rodriguez-Merchan EC, Magallon M, Manso F, Martin-Villar J. Septic arthritis in HIV positive haemophiliacs. Four cases and a literature review. Int Orthop. 1992;16:302–6.
Heim M, Varon D, Strauss S, Martinowitz U. The management of a person with haemophilia who has a fixed flexed hip and intractable pain. Haemophilia. 1998;4:842–4.
Klamroth R, Gottstein S, Essers E, Landgraf H, Wilaschek M, Oldenburg J. Successful angiographic embolization of recurrent elbow and knee joint bleeds in seven patients with severe haemophilia. Haemophilia. 2009;15:247–52.
Mauser-Bunschoten EP, Zijl JA, Mali W, van Rinsum AC, van den Berg HM, Roosendaal G. Successful treatment of severe bleeding in hemophilic target joints by selective angiographic embolization. Blood. 2005;105:2654–7.
Rodriguez-Merchan EC. Methods to treat chronic haemophilic synovitis. Haemophilia. 2001;7:1–5.
Galli E, Baques A, Moretti N, Candela M, Caviglia H. Hemophilic chronic synovitis: therapy of hemarthrosis using endovascular embolization of knee and elbow arteries. Cardiovasc Intervent Radiol. 2013;36:964–9.
Rodriguez-Merchan EC, Jimenez-Yuste V. The role of selective angiographic embolization of the musculo-skeletal system in haemophilia. Haemophilia. 2009;15:864–8.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Rodríguez-Merchán, E.C., De la Corte-Rodríguez, H. (2022). Management of Acute Hemarthrosis in Hemophilia (Including Joint Aspiration). In: Rodríguez-Merchán, E.C. (eds) Advances in Hemophilia Treatment . Springer, Cham. https://doi.org/10.1007/978-3-030-93990-8_13
Download citation
DOI: https://doi.org/10.1007/978-3-030-93990-8_13
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-93989-2
Online ISBN: 978-3-030-93990-8
eBook Packages: MedicineMedicine (R0)